Dr Raj Chovatiya Provides Evidence Supporting Oral JAK Inhibitor Use to Treat AD
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University of Medicine and Science, provided current clinical evidence supporting the use of oral Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD).